XT
WINT

XTX Topco’s Windtree Therapeutics WINT Stock Holding History

XTX Topco’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-389
Closed -$6.8K – 3193
2024
Q4 		$6.8K Buy
+389
New +$12.3K ﹤0.01% 2184

Other funds holding WINT

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

XTX Topco's WINT Position: Q1 2025 in Review

XTX Topco sold out of Windtree Therapeutics (WINT) in Q1 2025, closing a stake of 389 shares — an estimated $6.8K sold.

XTX Topco first reported a position in WINT in Q4 2024 and held it in 1 quarter. The position peaked at $6.8K in Q4 2024. 5 funds tracked by Wall St. Rank hold WINT as of Q1 2025.

  • XTX Topco reported no remaining Windtree Therapeutics position as of Q1 2025 after selling out during the quarter.
  • XTX Topco sold 389 Windtree Therapeutics shares in Q1 2025, an estimated $6.8K.
  • XTX Topco first reported a position in Windtree Therapeutics in Q4 2024 and held it in 1 quarter.
  • XTX Topco's Windtree Therapeutics position peaked at $6.8K in Q4 2024.
  • 5 funds tracked by Wall St. Rank held Windtree Therapeutics as of Q1 2025.

Based on XTX Topco's 13F filing for Q1 2025, filed 8 May 2025.